EPAR members and EPAR itself are known worldwide for their work in the field of the investigation of allergy and respiratory disease. They have participated and still participate in several research, education and advocacy initiatives. From the point of view of research, EPAR is involved in the following international and national ongoing collaborative scientific projects (as Work Package Leader), which allow EPAR to be included in the most updated research projects on allergic and respiratory diseases and to exchange with outstanding experts in the field. Findings from such studies will be published in peer-review journals
At the international level:
- SINPHONIE (Schools Indoor Pollution and Health: Observatory Network in Europe) (DG-SANCO) (WP Leadership)
- PHASE (Public Health Adaptation Strategies to extreme weather events) (DG-SANCO) (WP Leadership).
- MeDALL (Mechanisms of the Development of Allergy) (FP7 project) and its ancillary projects (CHICOS...)
- ESCAPE (European Study of Cohorts for Air Pollution Effects)
- ECRHS III (European Community Respiratory Health Survey-Phase III)
- ITCH (Genetics of drug allergy)
- PROTECT (IMI, EMA project, drug allergy)
At the national level, major ongoing funded projects include: EDEN ((WP Leadership), EGEA ((Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy) and Asthm’child), FERMA, TAP, ELFE...
In addition, EPAR will promote research, knowledge and advocacy on allergic and respiratory diseases through its partnership with national and international networks (GA2LEN, Global Allergy and Asthma European Network, funded by the European Union, WHO GARD Global Alliance against Respiratory Diseases), WHO ARIA (Allergic rhinitis initiative in asthma)...) and collaborations with national and international agencies, medical societies, and scientific programming communities (European respiratory Society (ERS): Clinical Assembly, Occupation and Epidemiology Assembly and Paediatric Assembly, European Academy of Allergy and Clinical Immunology (EAACI): Paediatrics section and Aerobiology and air pollution Interest Group), American Thoracic Society (ATS), International Union against Tuberculosis and Lung Diseases (IUATLD), International Respiratory Clinical Research network, Society of Pneumology of French Language (SPLF), National Committee to Fight against Lung Disease (CNMRT), French Office for the fight against Smoking, French Society of Allergology and Clinical Immunology (SFAIC), French Society of Pediatrics....).
EPAR will continue to contribute to the annual meetings of the European Respiratory Society (ERS), the European Academy of Allergy and Clinical Immunology (EAACI) (since 2010) and the American Thoracic Society (ATS) (since 2011), Congrès de Pneumologie de Langue Française (CPLF), Congrès Francophone d’Allergologie (CFA), J2R (Respiratory Days).
EPAR educational activities will continue besides teaching at various University degrees (Medical School, Master degrees, Specialty School, EAACI and ERS Schools...) by proposing Master and PhD projects in France and abroad.
The nature of the team approaches to obtaining resources is threefold:
1. Providing a home ground for students, especially those in specialized courses in pulmonology and allergology, for M2 and PhD/doctoral university as part of the Graduate School of Epidemiological - Public Health of Paris VI. Students from abroad are welcome;
2. Apply to national and international tenders;
3. Establish private partnerships.
4. Implement licences (in allergology (Medall epigenetic project))